-
05 August 2026 15:42:14
- Source: Sharecast
5 August 2026
CVS Group plc
("CVS" or the "Company")
PDMR Dealing
CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 5 August 2026 that David Wilton, Non-executive Chairman of the Company, purchased a total of 1,500 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on 4 August 2026.
As a result, David Wilton's total interest in the Company, including all persons closely associated, is now at 14,000 Ordinary Shares, representing 0.02% per cent of the total voting rights of the Company.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
Contacts:
CVS Group plc via FGS Global
Richard Fairman, CEO
Scott Morrison, Company Secretary
FGS Global (Financial PR)
Faeth Birch +44 (0)207 251 3801
Charlie Chichester cvsgroup@fgsglobal.com
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a)
|
Name |
David Wilton |
||||
|
2
|
Reason for the notification
|
|||||
|
a)
|
Position/status
|
PDMR (Chairman) |
||||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
|
a)
|
Name
|
CVS Group plc |
||||
|
b)
|
LEI
|
213800J41XDQ2NX48O05 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 0.2 pence each
GB00B2863827
|
||||
|
b)
|
Nature of the transaction
|
On-market purchase |
||||
|
c)
|
Price(s) and volume(s)
|
|
||||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A - single transaction |
||||
|
e)
|
Date of the transaction
|
4 August 2026 |
||||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON) |
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.